Harrison & Star lands Roche Pegasys account

Share this article:
Roche switched professional agencies for its top-selling hepatitis C therapy Pegasys to Omnicom’s Harrison & Star from echo Torre Lazur, part of Interpublic Group’s McCann Healthcare Worldwide. The move followed a three-way pitch among Harrison & Star, GSW and one other agency. Pegasys is the world’s best-selling treatment for chronic hepatitis C. The drug brought in $1.13 billion in revenue last year, a 17% increase over 2004.
Share this article:
You must be a registered member of MMM to post a comment.

Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.